BIONET TECHNOLOGIES INC
10KSB, EX-27, 2000-05-30
PHARMACEUTICAL PREPARATIONS
Previous: BIONET TECHNOLOGIES INC, 10KSB, 2000-05-30
Next: BAILARD BIEHL & KAISER FUND GROUP INC, NSAR-A, 2000-05-30



<TABLE> <S> <C>

<ARTICLE> 5

<S>                                                               <C>
<PERIOD-TYPE>                                                    YEAR
<FISCAL-YEAR-END>                                           JAN-31-2000
<PERIOD-END>                                                JAN-31-2000
<CASH>                                                          52,461
<SECURITIES>                                                   132,000
<RECEIVABLES>                                                        0
<ALLOWANCES>                                                         0
<INVENTORY>                                                          0
<CURRENT-ASSETS>                                               181,174
<PP&E>                                                          96,779
<DEPRECIATION>                                                  32,580
<TOTAL-ASSETS>                                                 372,417
<CURRENT-LIABILITIES>                                           66,192
<BONDS>                                                              0
<COMMON>                                                        11,712
                                                0
                                                          5
<OTHER-SE>                                                     294,508
<TOTAL-LIABILITY-AND-EQUITY>                                   306,225
<SALES>                                                              0
<TOTAL-REVENUES>                                                     0
<CGS>                                                                0
<TOTAL-COSTS>                                                        0
<OTHER-EXPENSES>                                             1,727,948
<LOSS-PROVISION>                                                     0
<INTEREST-EXPENSE>                                               1,145
<INCOME-PRETAX>                                             (1,707,318)
<INCOME-TAX>                                                         0
<INCOME-CONTINUING>                                         (1,707,318)
<DISCONTINUED>                                                       0
<EXTRAORDINARY>                                                      0
<CHANGES>                                                            0
<NET-INCOME>                                                (1,707,318)
<EPS-BASIC>                                                     (.17)
<EPS-DILUTED>                                                     (.17)



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission